Marijuana time
A GOP lawmaker says the top of the Nationwide Institute on Drug Abuse (NIDA) opposes rescheduling marijuana, even supposing his company has formally agreed to a advice to implement reform and to the director's repeated public feedback criticizing the analysis obstacles imposed by the present standing of Schedule I hashish.
NIDA Director Nora Volkow
Whereas Rep. Andy Harris (R-MD) mentioned throughout a Home Appropriations Committee listening to Thursday that NIDA Director Nora Volkow is “vehemently opposed” to rescheduling hashish, the company refused to help it. this place in a press release to Marijuana Second, as a substitute of indicating. the director's previous remarks and different supplies describing how researchers face onerous obstacles in conducting research on hashish due to its Schedule I standing underneath the Managed Substances Act (CSA).
…/…
Nonetheless, Harris informed the top of the Meals and Drug Administration (FDA) throughout Thursday's listening to that Volkow herself is against the reclassification, in addition to any transfer to make “marijuana extra extensively accessible.” Congress requested FDA Commissioner Robert Califf if he had mentioned the difficulty with the director of NIDA, after which requested him if he was “conscious” of his place.
“I'm conscious of their views, sure,” Califf mentioned, refusing to defer to the rescheduling request.
Supply: https://www.marijuanamoment.internet/gop-congressman-claims-top-federal-drug-official-adamantly-opposes-marijuana-rescheduling-but-agency-endorsed-fda-recommendation/
